191 related articles for article (PubMed ID: 37236385)
1. Emerging concepts towards a translational framework in Alzheimer's disease.
Cozachenco D; Zimmer ER; Lourenco MV
Neurosci Biobehav Rev; 2023 Sep; 152():105246. PubMed ID: 37236385
[TBL] [Abstract][Full Text] [Related]
2. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease (AD) therapeutics - 2: Beyond amyloid - Re-defining AD and its causality to discover effective therapeutics.
Mullane K; Williams M
Biochem Pharmacol; 2018 Dec; 158():376-401. PubMed ID: 30273552
[TBL] [Abstract][Full Text] [Related]
4. Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies.
Golde TE
J Neurochem; 2016 Oct; 139 Suppl 2(Suppl 2):224-236. PubMed ID: 27145445
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis, Animal Models, and Drug Discovery of Alzheimer's Disease.
Xia ZD; Ma RX; Wen JF; Zhai YF; Wang YQ; Wang FY; Liu D; Zhao XL; Sun B; Jia P; Zheng XH
J Alzheimers Dis; 2023; 94(4):1265-1301. PubMed ID: 37424469
[TBL] [Abstract][Full Text] [Related]
6. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
8. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.
Hampel H; Lista S; Teipel SJ; Garaci F; Nisticò R; Blennow K; Zetterberg H; Bertram L; Duyckaerts C; Bakardjian H; Drzezga A; Colliot O; Epelbaum S; Broich K; Lehéricy S; Brice A; Khachaturian ZS; Aisen PS; Dubois B
Biochem Pharmacol; 2014 Apr; 88(4):426-49. PubMed ID: 24275164
[TBL] [Abstract][Full Text] [Related]
9. Fluid Biomarkers in Clinical Trials for Alzheimer's Disease: Current and Future Application.
Yang J; Jia L; Li Y; Qiu Q; Quan M; Jia J
J Alzheimers Dis; 2021; 81(1):19-32. PubMed ID: 33749646
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
Mullane K; Williams M
Biochem Pharmacol; 2020 Jul; 177():113945. PubMed ID: 32247851
[TBL] [Abstract][Full Text] [Related]
11. Role of Post-translational Modifications in Alzheimer's Disease.
Ramesh M; Gopinath P; Govindaraju T
Chembiochem; 2020 Apr; 21(8):1052-1079. PubMed ID: 31863723
[TBL] [Abstract][Full Text] [Related]
12. Molecular PET imaging in multicenter Alzheimer's therapeutic trials: current trends and implementation strategies.
Seibyl J; Zubal IG; Jennings D; Marek K; Doraiswamy PM
Expert Rev Neurother; 2011 Dec; 11(12):1783-93. PubMed ID: 22091601
[TBL] [Abstract][Full Text] [Related]
13. Down syndrome and Alzheimer's disease: Common pathways, common goals.
Hartley D; Blumenthal T; Carrillo M; DiPaolo G; Esralew L; Gardiner K; Granholm AC; Iqbal K; Krams M; Lemere C; Lott I; Mobley W; Ness S; Nixon R; Potter H; Reeves R; Sabbagh M; Silverman W; Tycko B; Whitten M; Wisniewski T
Alzheimers Dement; 2015 Jun; 11(6):700-9. PubMed ID: 25510383
[TBL] [Abstract][Full Text] [Related]
14. Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression.
Tok S; Ahnaou A; Drinkenburg W
J Alzheimers Dis; 2022; 88(3):809-836. PubMed ID: 34420957
[TBL] [Abstract][Full Text] [Related]
15. Accelerating Alzheimer's disease drug discovery and development: what's the way forward?
Imbimbo BP; Ippati S; Watling M; Balducci C
Expert Opin Drug Discov; 2021 Jul; 16(7):727-735. PubMed ID: 33653187
[No Abstract] [Full Text] [Related]
16. Omics-based biomarkers discovery for Alzheimer's disease.
Aerqin Q; Wang ZT; Wu KM; He XY; Dong Q; Yu JT
Cell Mol Life Sci; 2022 Nov; 79(12):585. PubMed ID: 36348101
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and Alzheimer's disease crosstalk.
Baglietto-Vargas D; Shi J; Yaeger DM; Ager R; LaFerla FM
Neurosci Biobehav Rev; 2016 May; 64():272-87. PubMed ID: 26969101
[TBL] [Abstract][Full Text] [Related]
18. Lost in Translation? Finding Our Way To Effective Alzheimer's Disease Therapies.
Quinn JF
J Alzheimers Dis; 2018; 64(s1):S33-S39. PubMed ID: 29758942
[TBL] [Abstract][Full Text] [Related]
19. Advance of sporadic Alzheimer's disease animal models.
Zhang L; Chen C; Mak MS; Lu J; Wu Z; Chen Q; Han Y; Li Y; Pi R
Med Res Rev; 2020 Jan; 40(1):431-458. PubMed ID: 31328804
[TBL] [Abstract][Full Text] [Related]
20. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P
J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
